Skip to main content
. 2017 Jan 31;7:41170. doi: 10.1038/srep41170

Figure 2.

Figure 2

Cumulative (sub)hazards for (a) all-cause, (b) cardiovascular, (c) infection-related, and (d) malignancy-related death in the matched cohort of 8,568 patients including 3,203 VDRA users and 5,365 non-VDRA users as of the end of 2009. Abbreviation: VDRA, vitamin D receptor activator.